FDA grants single-patient expanded access for urcosimod in neuropathic corneal pain | Optometry Times - Clinical News

Published on January 26, 2026
FDA authorizes compassionate use of urcosimod for neuropathic corneal pain, a condition that causes severe pain and sensitivity of the eyes, face, or head.
Continue reading on website
Other news

Integrating nutrition, oculomics, genetics, and photobiomodulation for macular degeneration | Optometry Times - Clinical News

January 26, 2026
Understanding AMD pathophysiology through nutrition has helped shape the disease’s detection and management.

Malnutrition Associated with Early-stage AMD

January 27, 2026
This retrospective study revealed a progressive decline in nutritional status from the control group to AMD to AMD-RPD. Patients with AMD and AMD-RPD also had significantly reduced choroidal vascular index compared to controls, indicating that poorer nutritional status is associated with lower CVI. The above chart from the study shows the positive predictive value all three scores showed in distin